Abstract
Myanmar Context & Rationale
- More malaria than any other country in GMS (70% of total)
- Commitment to eliminate malaria by 2030
- Oral artemisinin monotherapy (AMT) was banned since 2012
- Yet, sale and use of oral AMT is still common
This resource is no longer maintained!
For up-to-date publications on reproductive health, please visit the RHSC’s publications database, with 3,000 records. If you would like to take on the management and development of Market Bookshelf, please contact us at https://www.rhsupplies.org/contact-us/.